Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HB-adMSCs vs Placebo for Parkinson's Disease
NCT04928287Phase 2Completed
- Sponsor
- Hope Biosciences
- Start
- Jun 2021
- Primary completion
- Feb 2023
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of allogeneic HB-adMSCs in Parkinson's disease (PD), sponsored by Hope Biosciences. Started Jun 2021; status: completed.
02
Drugs
allogeneic HB-adMSCs
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT04928287.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04928287.